Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David White
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Apnimed, Inc.
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. White has a financial interest in Apnimed, Inc., a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders. Dr. White is the Chair of the company’s Advisory Board and receives compensation for serving in this role. The research project seeks to better understand the underlying molecular and physiological mechanisms for obstructive sleep apnea, with the goal of further improving and refining sleep apnea phenotypes. If the research is successful, the results may facilitate new, targeted treatments, influencing Apnimed’s development efforts. The Partners Committee on Outside Activities reviewed the financial interest in connection with the research and determined that the financial interest could directly and significantly affect the design, conduct, or reporting of the research. The committee further determined that the conflict could be managed with the implementation of an FCOI management plan.
Phenotypic and Molecular Signatures for Sleep Apnea and Related Morbidities
Sleep apnea is a common disorder associated with many adverse health outcomes, but often unrecognized and under-treated. The usual measure of disease severity, the Apnea Hypopnea Index, does not adequately characterize disease subtypes reflective of differences in underlying anatomic and physiological risk factors, and thus poorly predicts which patients are most susceptible to adverse health outcomes and would benefit from treatment. The mainstay treatment is a CPAP machine, which stents the airway open without treating the underlying cause of the apnea. This program will systematically identify new measures of sleep apnea that reflect underlying mechanisms and allow subgroups of patients to be better characterized, facilitating the discovery of the molecular basis for sleep apnea and novel treatments.
Filed on June 03, 2019.
Tell us what you know about David White's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “David White”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David White | Brigham and Women's Hospital | Conflict of Interest | Apnimed Corp. | $20,000 - $39,999 |
| David White | Brigham and Women's Hospital | Conflict of Interest | Philips Respironics | $80,000 - $99,999 |
| David White | Brigham and Women's Hospital | Conflict of Interest | Apnicure, Inc. | Value cannot be readily determined |
| David White | Brigham and Women's Hospital | Conflict of Interest | Apnicure, Inc. | $100,000 - $149,999 |
| David White | Brigham and Women's Hospital | Conflict of Interest | Phillips Respironics | $150,000 - $199,999 |
| David White | Brigham and Women's Hospital | Conflict of Interest | Philips Respironics | $300,000 - $349,999 |
| David White | Brigham and Women's Hospital | Conflict of Interest | Philips Respironics | $250,000 - $299,999 |
| David White | Beth Israel Deaconess Medical Center | Conflict of Interest | Philips Respironics | $300,000 - $349,999 |
| David White | Brigham and Women's Hospital | Conflict of Interest | Apnimed, Inc. | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.